Literature DB >> 30206323

Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism.

Shinji Kishimoto1, Takeshi Matsumoto2, Kenji Oki3, Tatsuya Maruhashi4, Masato Kajikawa5, Shogo Matsui4, Haruki Hashimoto4, Yasuki Kihara4, Farina Mohamad Yusoff1, Yukihito Higashi6,7.   

Abstract

The aims were to evaluate the relationship between idiopathic hyperaldosteronism (IHA) and grade of vascular function in the macrovasculature and microvasculature. Vascular function, including reactive hyperemia index (RIH), flow-mediated vasodilation (FMD), and nitroglycerine-induced vasodilation (NID) were evaluated in 52 patients with IHA, 53 patients with aldosterone-producing adenoma (APA), and 52 age-, sex-, and blood pressure-matched patients with essential hypertension (EHT). Log RHI was lower in the IHA and APA groups than in the EHT group (0.54 ± 0.25 and 0.55 ± 0.23 versus 0.79 ± 0.28; P < 0.01, respectively). FMD was lower in the APA group than in the EHT group (3.4 ± 2.1% versus 4.8 ± 2.8%; P = 0.02), whereas there was no significant difference in FMD between the IHA and the APA and EHT groups. NID was lower in the APA group than in the EHT group (10.0 ± 4.5% versus 12.5 ± 5.7%; P = 0.03), whereas there was no significant difference in NID between the IHA, APA, and EHT groups. Multiple regression analysis revealed an association of log RHI with plasma aldosterone concentration (t = -2.24; P = 0.03) and an association of FMD with plasma aldosterone concentration (t = -3.07; P < 0.01). Microvascular endothelial function was impaired in patients with IHA compared with that in patients with EHT.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30206323     DOI: 10.1038/s41440-018-0093-6

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

1.  Comparison of the shortened and standard saline infusion tests for primary aldosteronism diagnostics.

Authors:  Kaoru Yamashita; Midori Yatabe; Yasufumi Seki; Kanako Bokuda; Daisuke Watanabe; Satoru Shimizu; Satoshi Morimoto; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2020-05-08       Impact factor: 3.872

2.  A Case of a Pregnant Woman With Primary Aldosteronism and Superimposed Preeclampsia Treated With Esaxerenone.

Authors:  Kaoru Yamashita; Satoshi Morimoto; Yuko Inoue; Kiyotaka Hirata; Shihori Kimura; Yasufumi Seki; Kanako Bokuda; Daisuke Watanabe; Atsuhiro Ichihara
Journal:  J Endocr Soc       Date:  2022-05-29

3.  Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism.

Authors:  Kaoru Yamashita; Satoshi Morimoto; Yasufumi Seki; Daisuke Watanabe; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2019-08-13       Impact factor: 3.872

Review 4.  Endothelial Dysfunction in Primary Aldosteronism.

Authors:  Zheng-Wei Chen; Cheng-Hsuan Tsai; Chien-Ting Pan; Chia-Hung Chou; Che-Wei Liao; Chi-Sheng Hung; Vin-Cent Wu; Yen-Hung Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

5.  Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension.

Authors:  Miaomiao Sang; Yu Fu; Chenmin Wei; Jing Yang; Xueting Qiu; Jingqing Ma; Chao Qin; Feiyan Wu; Xueling Zhou; Tao Yang; Min Sun
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021 Jan-Dec       Impact factor: 1.636

6.  Clinical impacts of endothelium-dependent flow-mediated vasodilation assessment on primary aldosteronism.

Authors:  Daisuke Watanabe; Satoshi Morimoto; Noriko Morishima; Atsuhiro Ichihara
Journal:  Endocr Connect       Date:  2021-06-08       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.